MOLINA HEALTHCARE, INC.

MOH· FY2025 10-K· Analyzed 1 mo ago
PASS
Growth Rates — CAGR from SEC 10-K XBRL filings
Revenue
12.3%
FY2015–2025
Net Income
14.2%
FY2015–2025
Free Cash Flow
-7.2%
FY2015–2025
EPS (Diluted)
14.8%
FY2015–2025
Latest Metrics — FY2025 · SEC XBRL
Return on Equity
11.6%
NI ÷ Equity
Return on Assets
3.0%
NI ÷ Assets
Net Profit Margin
1.0%
NI ÷ Revenue
Debt / Equity
0.93x
LT Debt ÷ Equity
Intrinsic Value Estimate — DCF (10% discount · 3% terminal · FCF growth capped 15%)
Total Business Value
$9.7B
Per Share (approx.)
$190.00
25% Margin of Safety
$142.50
Conservative entry
50% Margin of Safety
$95.00
Buffett's ideal entry
Growth Rate Used
8.0%
Latest FCF
$454.9M

Berkshire requires a 25–50% discount to intrinsic value before buying.

Buffett Quality Checklist
ROE >15% consistently (≥7 of last 10 years)
Free cash flow positive (≥8 of last 10 years)
Conservative leverage — Debt/Equity below 1
Revenue growing at CAGR >5%
EPS growing at CAGR >5%
10-Year Financial History — SEC EDGAR 10-K Filings
YearRevenueNet IncomeFCFOwner EarningsROENet MarginLT DebtCash
2016$17.8B$52.0M$497.0M$58.0M3.2%0.3%$1.4B$2.8B
2017$19.9B-$512.0M$718.0M-$420.0M-38.3%-2.6%$1.3B$3.2B
2018$18.9B$707.0M-$344.0M$804.0M42.9%3.7%$1.0B$2.8B
2019$16.8B$737.0M$377.0M$769.0M37.6%4.4%$1.2B$2.5B
2020$19.4B$673.0M$1.8B$687.0M32.1%3.5%$2.1B$4.2B
2021$27.8B$659.0M$2.0B$713.0M25.1%2.4%$2.2B$4.4B
2022$32.0B$792.0M$682.0M$877.0M26.7%2.5%$2.2B$4.0B
2023$34.1B$1.1B$1.6B$1.2B25.9%3.2%$2.2B$4.8B
2024$40.6B$1.2B$544.0M$1.3B26.2%2.9%$2.9B$4.7B
2025$45.4B$472.0M-$636.0M$566.0M11.6%1.0%$3.8B$4.2B
Warren & Charlie
Buffett / Munger — quality, moat & valuation

MOLINA HEALTHCARE, INC. (MOH) — Investment Memo

🐂 The Bull Case (Warren's voice)

  • The Indispensable Utility: At its core, Molina is an outsourced administrator for government policy. States do not want to manage the bureaucratic headache of Medicaid delivery; they want to pay a fixed fee to a private entity to handle the headaches. That makes Molina a utility.
  • Scale as a Barrier: In a business where you are paid a fixed premium to manage unpredictable health risks, size matters. Molina’s ability to aggregate data across millions of members allows them to price risk more accurately than smaller, local competitors.
  • Structural Durability: The demand for Medicaid and Marketplace coverage is counter-cyclical. When the economy suffers, enrollment rises. This provides a natural hedge that few other industries enjoy, ensuring revenue consistency regardless of interest rates or GDP growth.
  • The "Right Price" Opportunity: If management ever pivots from "empire building" to "capital return"—specifically, using their massive $45.4B revenue base to generate actual, undistorted free cash flow—the business could become a highly efficient cash machine. We look for companies where the moat is wide, even if the current operator is occasionally clumsy.

🐻 The Bear Case (Charlie inverts)

Munger's rule: "Show me where I'll die and I won't go there."

  • The Regulatory Guillotine: The business survives only at the mercy of state legislatures. If a state decides their Medicaid budget is too high, they don't trim the program; they cut the reimbursement rates paid to the insurer. Molina has zero pricing power. A single legislative session can turn a profit into a loss overnight.
  • The "Winner’s Curse" of Growth: When you grow revenue from $17.8B to $45.4B while margins crater to 1.0%, you aren't building a business; you are participating in an auction where the prize goes to the person willing to take the lowest profit. This is institutionalized stupidity—the race to the bottom of the actuarial table.
  • Accounting Mirage: When a company reports $0.5B in Net Income but hemorrhages $0.6B in Free Cash Flow, you aren't looking at earnings; you're looking at a bookkeeping entry that will eventually hit a wall. The accountants are working too hard. This is a business that consumes capital to exist, which is the definition of a value destroyer.
  • Verdict on Survivability: The most likely path to death is a combination of actuarial miscalculation (underestimating the medical loss ratio) and the subsequent regulatory clawbacks. It’s a permanent risk that cannot be mitigated by diversification.

💰 Valuation & Margin of Safety

The DCF model assumes an 8% growth rate, but the current negative Free Cash Flow makes that assumption appear generous, if not heroic. We must separate the math from the reality.

  • Intrinsic value estimate: $190.00 per share.
  • 25% margin of safety entry: $142.50 (Conservative)
  • 50% margin of safety entry: $95.00 (Buffett's ideal)

Note: Given the alarming disconnect between reported earnings and cash generation, we would demand a significant discount to even consider looking at the balance sheet. At current levels, the market is pricing in efficiency that management has yet to prove they can deliver.


Verdict: PASS

We are passing on Molina because a business that requires massive scale to generate a 1.0% margin is a business that lacks a durable competitive advantage. The divergence between their accounting "profits" and their actual cash outflow is a red flag that suggests the underlying economics are far weaker than the headline revenue numbers imply. We prefer to own businesses that generate cash, not those that merely facilitate the movement of government dollars while destroying shareholder capital in the process.

Research Notes· Money Model · Moat · Financials · Management

Data sourced from SEC EDGAR XBRL filings (10-K only). For educational purposes — not investment advice.